• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用同位素手性[4'-13C]泛昔洛韦和13C核磁共振来鉴定人肠壁提取物将泛昔洛韦转化为喷昔洛韦过程中的手性单乙酰化中间体。

Use of isotopically chiral [4'-13C]famciclovir and 13C NMR to identify the chiral monoacetylated intermediates in the conversion of famciclovir to penciclovir by human intestinal wall extract.

作者信息

Vere Hodge R A, Darlison S J, Readshaw S A

机构信息

SmithKline Beecham Pharmaceuticals, Epsom, Surrey, England.

出版信息

Chirality. 1993;5(8):577-82. doi: 10.1002/chir.530050803.

DOI:10.1002/chir.530050803
PMID:8305284
Abstract

Famciclovir is the oral form of the potent antiherpesvirus agent, penciclovir. Hydrolysis of one of the acetyl ester groups of famciclovir creates a chiral centre leading to the possible formation of (R)- and (S)-enantiomers. During its conversion to penciclovir, famciclovir forms two chiral metabolites, namely monoacetyl-6-deoxy-penciclovir and monoacetyl-penciclovir. The absolute configuration and stereospecificity of the monoacetyl metabolites of famciclovir, produced in human intestinal wall extract, were determined using isotopically chiral famciclovir and 13C NMR spectroscopy of the isolated metabolites. 13C NMR showed that the esterase(s), in human intestinal wall extract, hydrolysed the acetyl group preferentially from the pro-(S)-acetoxymethyl group of famciclovir. The specificity of esterase action in forming monoacetyl-6-deoxy-penciclovir and monoacetyl-penciclovir was about 77 and 72%, respectively.

摘要

泛昔洛韦是强效抗疱疹病毒药物喷昔洛韦的口服剂型。泛昔洛韦的一个乙酰酯基团水解会产生一个手性中心,导致可能形成(R)-和(S)-对映体。在转化为喷昔洛韦的过程中,泛昔洛韦形成两种手性代谢物,即单乙酰-6-脱氧喷昔洛韦和单乙酰喷昔洛韦。使用同位素手性泛昔洛韦和分离代谢物的13C NMR光谱法,测定了人肠壁提取物中产生的泛昔洛韦单乙酰代谢物的绝对构型和立体特异性。13C NMR表明,人肠壁提取物中的酯酶优先从泛昔洛韦的前-(S)-乙酰氧基甲基基团水解乙酰基。酯酶作用形成单乙酰-6-脱氧喷昔洛韦和单乙酰喷昔洛韦的特异性分别约为77%和72%。

相似文献

1
Use of isotopically chiral [4'-13C]famciclovir and 13C NMR to identify the chiral monoacetylated intermediates in the conversion of famciclovir to penciclovir by human intestinal wall extract.使用同位素手性[4'-13C]泛昔洛韦和13C核磁共振来鉴定人肠壁提取物将泛昔洛韦转化为喷昔洛韦过程中的手性单乙酰化中间体。
Chirality. 1993;5(8):577-82. doi: 10.1002/chir.530050803.
2
Use of isotopically chiral [4'-13C]penciclovir and 13C NMR to determine the specificity and absolute configuration of penciclovir phosphate esters formed in HSV-1 and HSV-2 infected cells and by HSV-1-encoded thymidine kinase.使用同位素手性[4'-13C]喷昔洛韦和13C核磁共振来确定在单纯疱疹病毒1型(HSV-1)和单纯疱疹病毒2型(HSV-2)感染细胞中以及由HSV-1编码的胸苷激酶形成的喷昔洛韦磷酸酯的特异性和绝对构型。
Chirality. 1993;5(8):583-8. doi: 10.1002/chir.530050804.
3
Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir].为抗疱疹病毒药物BRL 39123 [9-(4-羟基-3-羟甲基丁-1-基)鸟嘌呤;喷昔洛韦]选择一种口服前体药物(BRL 42810;泛昔洛韦)。
Antimicrob Agents Chemother. 1989 Oct;33(10):1765-73. doi: 10.1128/AAC.33.10.1765.
4
Metabolic and pharmacokinetic studies following oral administration of famciclovir to the rat and dog.对大鼠和犬口服泛昔洛韦后的代谢及药代动力学研究。
Xenobiotica. 1995 May;25(5):477-90. doi: 10.3109/00498259509061867.
5
Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers.对健康志愿者单次口服125、250、500和750毫克泛昔洛韦后喷昔洛韦的线性药代动力学。
J Antimicrob Chemother. 1994 Jan;33(1):119-27. doi: 10.1093/jac/33.1.119.
6
Role of aldehyde oxidase in the in vitro conversion of famciclovir to penciclovir in human liver.醛氧化酶在人肝脏中体外将泛昔洛韦转化为喷昔洛韦的作用。
Drug Metab Dispos. 1995 Feb;23(2):251-4.
7
Pharmacokinetics of penciclovir in healthy cats following oral administration of famciclovir or intravenous infusion of penciclovir.口服泛昔洛韦或静脉输注喷昔洛韦后,喷昔洛韦在健康猫体内的药代动力学。
Am J Vet Res. 2012 Jul;73(7):1092-9. doi: 10.2460/ajvr.73.7.1092.
8
In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver.人、豚鼠、兔和大鼠肝脏醛氧化酶对泛昔洛韦和6-脱氧喷昔洛韦的体外氧化作用。
Drug Metab Dispos. 1997 Jul;25(7):805-13.
9
Evidence that famciclovir (BRL 42810) and its associated metabolites do not inhibit the 6 beta-hydroxylation of testosterone in human liver microsomes.泛昔洛韦(BRL 42810)及其相关代谢产物不会抑制人肝微粒体中睾酮6β-羟基化作用的证据。
Drug Metab Dispos. 1993 Jan-Feb;21(1):18-23.
10
Pharmacokinetics of famciclovir and penciclovir in tears following oral administration of famciclovir to cats: a pilot study.猫口服泛昔洛韦后泪液中泛昔洛韦和喷昔洛韦的药代动力学:一项初步研究。
Vet Ophthalmol. 2012 Sep;15(5):299-306. doi: 10.1111/j.1463-5224.2011.00984.x. Epub 2012 Feb 16.

引用本文的文献

1
Prodrug strategies for improved efficacy of nucleoside antiviral inhibitors.前药策略提高核苷类抗病毒抑制剂的疗效。
Curr Opin HIV AIDS. 2013 Nov;8(6):556-64. doi: 10.1097/COH.0000000000000007.
2
A review of famciclovir in the management of genital herpes.泛昔洛韦在生殖器疱疹治疗中的综述。
Infect Dis Obstet Gynecol. 1998;6(1):38-43. doi: 10.1002/(SICI)1098-0997(1998)6:1<38::AID-IDOG8>3.0.CO;2-3.
3
Acyclic nucleosides as antiviral compounds.无环核苷类作为抗病毒化合物。
Mol Biotechnol. 1996 Apr;5(2):125-37. doi: 10.1007/BF02789061.